The wait is over, ladies -- now you'll have your own little pink pill to bring back your sex drive (if need be)! On Tuesday, the U.S. Food and Drug Administration approved flibanserin for the treatment of sexual dysfunction in premenopausal women. (It will be sold under the name Addyi.) This is the first FDA-approved treatment for sexual desire in men or women. While some might consider it the female version of Viagra, Addyi is really in a category of its own. Viagra treats sexual desire -- it does not induce sexual desire. On the other hand, Addyi works on the central nervous system, which is why it falls into the same category as an antidepressant. Common side effects range from nausea and fatigue to dizziness and insomnia. Those who consume alcohol while taking Addyi are at higher risk for severe low blood pressure, which can lead to a temporary loss of consciousness. Addyi will cost about the same per month as a one month supply of Viagra for men. As with all other medi...